254 related articles for article (PubMed ID: 34663949)
1. Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.
Wheatley RC; Kilgour E; Jacobs T; Lamarca A; Hubner RA; Valle JW; McNamara MG
Br J Cancer; 2022 Mar; 126(5):693-705. PubMed ID: 34663949
[TBL] [Abstract][Full Text] [Related]
2. [Microbiome and Biliary Tract Cancer].
Park JS
Korean J Gastroenterol; 2024 Jan; 83(1):1-5. PubMed ID: 38268162
[TBL] [Abstract][Full Text] [Related]
3. 16S rDNA microbiome composition pattern analysis as a diagnostic biomarker for biliary tract cancer.
Lee H; Lee HK; Min SK; Lee WH
World J Surg Oncol; 2020 Jan; 18(1):19. PubMed ID: 31980025
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers.
Mao J; Wang D; Long J; Yang X; Lin J; Song Y; Xie F; Xun Z; Wang Y; Wang Y; Li Y; Sun H; Xue J; Song Y; Zuo B; Zhang J; Bian J; Zhang T; Yang X; Zhang L; Sang X; Zhao H
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34873013
[TBL] [Abstract][Full Text] [Related]
5. Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes.
Chen X; Wang D; Liu J; Qiu J; Zhou J; Ying J; Shi Y; Wang Z; Lou H; Cui J; Zhang J; Liu Y; Zhao F; Pan L; Zhao J; Zhu D; Chen S; Li X; Li X; Zhu L; Shao Y; Shu Y
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34795005
[TBL] [Abstract][Full Text] [Related]
6. Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy.
Ye C; Dong C; Lin Y; Shi H; Zhou W
Microorganisms; 2023 Oct; 11(10):. PubMed ID: 37894256
[TBL] [Abstract][Full Text] [Related]
7. Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
Lamarca A; Edeline J; McNamara MG; Hubner RA; Nagino M; Bridgewater J; Primrose J; Valle JW
Cancer Treat Rev; 2020 Mar; 84():101936. PubMed ID: 31986437
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapies in advanced biliary tract cancers-a narrative review.
LaPelusa M; Heumann T; Goff L; Agarwal R
Chin Clin Oncol; 2023 Apr; 12(2):14. PubMed ID: 36946186
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
Chae H; Kim D; Yoo C; Kim KP; Jeong JH; Chang HM; Lee SS; Park DH; Song TJ; Hwang S; Kim KH; Song GW; Ahn CS; Lee JH; Hwang DW; Kim SC; Jang SJ; Hong SM; Kim TW; Ryoo BY
Eur J Cancer; 2019 Oct; 120():31-39. PubMed ID: 31476489
[TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing for biliary tract cancers.
DiPeri TP; Javle MM; Meric-Bernstam F
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):471-474. PubMed ID: 33641586
[No Abstract] [Full Text] [Related]
11. New Horizons for Precision Medicine in Biliary Tract Cancers.
Valle JW; Lamarca A; Goyal L; Barriuso J; Zhu AX
Cancer Discov; 2017 Sep; 7(9):943-962. PubMed ID: 28818953
[TBL] [Abstract][Full Text] [Related]
12. The microbiome and hepatobiliary-pancreatic cancers.
Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
[TBL] [Abstract][Full Text] [Related]
13. Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers.
Conci S; Catalano G; Roman D; Zecchetto C; Lucin E; De Bellis M; Tripepi M; Guglielmi A; Milella M; Ruzzenente A
Int J Med Sci; 2023; 20(7):858-869. PubMed ID: 37324191
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota in Diagnosis, Therapy and Prognosis of Cholangiocarcinoma and Gallbladder Carcinoma-A Scoping Review.
Lederer AK; Rasel H; Kohnert E; Kreutz C; Huber R; Badr MT; Dellweg PKE; Bartsch F; Lang H
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764207
[TBL] [Abstract][Full Text] [Related]
15. The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
Berchuck JE; Facchinetti F; DiToro DF; Baiev I; Majeed U; Reyes S; Chen C; Zhang K; Sharman R; Uson Junior PLS; Maurer J; Shroff RT; Pritchard CC; Wu MJ; Catenacci DVT; Javle M; Friboulet L; Hollebecque A; Bardeesy N; Zhu AX; Lennerz JK; Tan B; Borad M; Parikh AR; Kiedrowski LA; Kelley RK; Mody K; Juric D; Goyal L
Ann Oncol; 2022 Dec; 33(12):1269-1283. PubMed ID: 36089135
[TBL] [Abstract][Full Text] [Related]
16. Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.
Oyasiji T; Zhang J; Kuvshinoff B; Iyer R; Hochwald SN
Oncologist; 2015 Jul; 20(7):742-51. PubMed ID: 26025932
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
18. Biliary tract carcinomas: from chemotherapy to targeted therapy.
Marino D; Leone F; Cavalloni G; Cagnazzo C; Aglietta M
Crit Rev Oncol Hematol; 2013 Feb; 85(2):136-48. PubMed ID: 22809696
[TBL] [Abstract][Full Text] [Related]
19. Advances in Targeted Immunotherapy for Hepatobiliary Cancers.
Ruff SM; Shannon AH; Pawlik TM
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430440
[TBL] [Abstract][Full Text] [Related]
20. Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair.
Lamarca A; Barriuso J; McNamara MG; Valle JW
Cancer Treat Rev; 2018 Nov; 70():168-177. PubMed ID: 30218788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
